tradingkey.logo

908 Devices Inc.

MASS
7.380USD
-0.420-5.38%
Cierre 11/07, 16:00ETCotizaciones retrasadas 15 min
266.10MCap. mercado
PérdidaP/E TTM

908 Devices Inc.

7.380
-0.420-5.38%

Más Datos de 908 Devices Inc. Compañía

908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.

Información de 908 Devices Inc.

Símbolo de cotizaciónMASS
Nombre de la empresa908 Devices Inc
Fecha de salida a bolsaDec 18, 2020
Director ejecutivoDr. Kevin J. Knopp, Ph.D.
Número de empleados246
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 18
Dirección645 Summer Street
CiudadBOSTON
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal02210
Teléfono19787294478
Sitio Webhttps://908devices.com/
Símbolo de cotizaciónMASS
Fecha de salida a bolsaDec 18, 2020
Director ejecutivoDr. Kevin J. Knopp, Ph.D.

Ejecutivos de 908 Devices Inc.

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.26M
+2.43%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
962.12K
--
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
74.33K
+18.05%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
+73.55%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
+81.60%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--
Dr. Brandi C. Vann, Ph.D.
Dr. Brandi C. Vann, Ph.D.
Independent Director
Independent Director
--
--
Jon Frattaroli
Jon Frattaroli
Vice President - Strategy
Vice President - Strategy
--
--
Mr. E. Kevin Hrusovsky
Mr. E. Kevin Hrusovsky
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Barbara Russo
Ms. Barbara Russo
Vice President - Marketing and Corporate Communications
Vice President - Marketing and Corporate Communications
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.26M
+2.43%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
962.12K
--
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
74.33K
+18.05%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
+73.55%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
+81.60%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Device sales revenue
8.28M
63.54%
Consumables and service revenue
4.73M
36.31%
License and contract revenue
20.00K
0.15%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
10.93M
83.85%
Europe,Middle East & Africa
1.37M
10.48%
Asia Pacific
671.00K
5.15%
Americas other
68.00K
0.52%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Device sales revenue
8.28M
63.54%
Consumables and service revenue
4.73M
36.31%
License and contract revenue
20.00K
0.15%

Estadísticas de accionistas

Actualizado: dom., 17 de ago
Actualizado: dom., 17 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
ARCH Venture Partners
15.87%
AWM Investment Company, Inc.
14.41%
State Street Investment Management (US)
6.34%
ARK Investment Management LLC
5.41%
BlackRock Institutional Trust Company, N.A.
4.48%
Otro
53.49%
Accionistas
Accionistas
Proporción
ARCH Venture Partners
15.87%
AWM Investment Company, Inc.
14.41%
State Street Investment Management (US)
6.34%
ARK Investment Management LLC
5.41%
BlackRock Institutional Trust Company, N.A.
4.48%
Otro
53.49%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
38.89%
Investment Advisor
22.60%
Venture Capital
15.88%
Individual Investor
8.36%
Hedge Fund
3.22%
Research Firm
2.16%
Pension Fund
0.17%
Bank and Trust
0.09%
Insurance Company
0.03%
Otro
8.60%

Participación institucional

Actualizado: dom., 5 de oct
Actualizado: dom., 5 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
223
29.97M
83.04%
-3.25M
2025Q2
226
29.86M
82.76%
-3.27M
2025Q1
235
29.47M
83.22%
+34.34K
2024Q4
242
25.43M
73.04%
-4.66M
2024Q3
246
27.53M
79.50%
-3.86M
2024Q2
248
28.48M
83.77%
-4.52M
2024Q1
241
29.63M
90.49%
-5.18M
2023Q4
255
31.02M
95.84%
-3.81M
2023Q3
261
30.10M
93.52%
-5.15M
2023Q2
268
30.29M
94.48%
-6.54M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
ARCH Venture Partners
5.73M
15.87%
--
--
Apr 17, 2025
AWM Investment Company, Inc.
5.20M
14.41%
--
--
Jun 30, 2025
State Street Investment Management (US)
2.29M
6.34%
+1.82M
+388.85%
Jun 30, 2025
ARK Investment Management LLC
2.65M
7.34%
-251.07K
-8.66%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.62M
4.48%
+115.41K
+7.69%
Jun 30, 2025
The Vanguard Group, Inc.
1.43M
3.97%
+68.94K
+5.06%
Jun 30, 2025
Knopp (Kevin J)
1.26M
3.5%
+30.00K
+2.43%
May 15, 2025
GM Advisory Group, LLC
1.17M
3.23%
+1.17M
--
Jun 30, 2025
First Light Asset Management, LLC
1.07M
2.96%
-633.48K
-37.24%
Jun 30, 2025
Brown (Christopher D)
962.12K
2.67%
--
--
Apr 17, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
ARK Genomic Revolution ETF
1.49%
SPDR S&P Kensho Future Security ETF
1.32%
SPDR S&P Kensho New Economies Composite ETF
0.57%
iShares Micro-Cap ETF
0.05%
Avantis US Small Cap Equity ETF
0.03%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Ver más
ARK Genomic Revolution ETF
Proporción1.49%
SPDR S&P Kensho Future Security ETF
Proporción1.32%
SPDR S&P Kensho New Economies Composite ETF
Proporción0.57%
iShares Micro-Cap ETF
Proporción0.05%
Avantis US Small Cap Equity ETF
Proporción0.03%
iShares Russell 2000 ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%
Global X Russell 2000 ETF
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI